Related Experiment Videos

Left-to-right shunting in common congenital heart defects: which patients are eligible for percutaneous

Werner Budts1, Marc Gewillig, Frans Van de Werf

  • 1Division of Cardiology and Congenital Cardiology, UZ Leuven, Belgium. Werner.Budts@uz.kuleuven.ac.be

Acta Cardiologica
|July 9, 2003
PubMed

Insights

Minimally invasive percutaneous closure is now available for common congenital heart defects like atrial and ventricular septal defects, offering a less painful and shorter hospital stay compared to traditional surgery.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Background:

  • Congenital heart defects such as atrial septal defects, atrioventricular septal defects, ventricular septal defects, and patent ductus arteriosus can lead to significant left-to-right shunting.
  • Chronic volume overload from these defects can cause pulmonary arterial hypertension and potentially lead to Eisenmenger syndrome.

Purpose of the Study:

  • To review the current status and benefits of percutaneous closure techniques for congenital heart defects.
  • To highlight the advantages of percutaneous closure over traditional surgical methods.

Main Methods:

  • Review of current literature on percutaneous closure of congenital heart defects.
  • Comparison of outcomes, patient tolerance, and hospital stay between percutaneous and surgical interventions.

Main Results:

  • Percutaneous closure is now feasible for patent ductus arteriosus, secundum atrial septal defects, and increasingly for muscular and perimembranous ventricular septal defects.
  • Percutaneous techniques significantly reduce post-procedural pain and shorten hospitalisation duration compared to surgery.
  • Favorable economic aspects are associated with percutaneous closure methods.

Conclusions:

  • Percutaneous closure offers a well-tolerated and effective alternative to surgery for specific congenital heart defects.
  • These minimally invasive techniques improve patient recovery and potentially reduce healthcare costs.
  • Continued development in percutaneous closure broadens treatment options for congenital heart disease.

Related Concept Videos